Moderna
Moderna is a biotechnology company that develops mRNA-based medicines, including vaccines for COVID-19 and RSV, with a pipeline spanning infectious diseases, oncology, rare diseases, and other therapeutic areas.
Moderna is a biotechnology company founded in 2010, headquartered in Cambridge, Massachusetts. It is a pioneer in messenger RNA (mRNA) medicine, having built one of the industry's leading mRNA technology platforms to develop transformative therapies. The company's approved products include SPIKEVAX, a COVID-19 vaccine, mRESVIA, an RSV vaccine, and mNEXSPIKE, another COVID-19 vaccine.
The company's pipeline spans multiple disease areas: infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. Moderna currently has 45 development programs and 36 ongoing clinical trials across these therapeutic areas. The company maintains 18 locations worldwide.
Moderna has committed to sustainability goals, pledging to achieve net-zero carbon emissions by 2030 in Scopes 1 and 2 and by 2045 in Scope 3.